The Core Value of Cost-Effectiveness Analyses
- PMID: 26764064
- PMCID: PMC5459408
- DOI: 10.1016/j.jacc.2015.11.013
The Core Value of Cost-Effectiveness Analyses
Keywords: aortic stenosis; appropriate use; cost-benefit analysis; heart valve prosthesis; quality-adjusted life-years; transcatheter valve therapy.
Comment on
-
Cost-Effectiveness of Transcatheter Aortic Valve Replacement With a Self-Expanding Prosthesis Versus Surgical Aortic Valve Replacement.J Am Coll Cardiol. 2016 Jan 5;67(1):29-38. doi: 10.1016/j.jacc.2015.10.046. J Am Coll Cardiol. 2016. PMID: 26764063 Free PMC article. Clinical Trial.
References
-
- Leon MB, Smith CR, Mack M, et al. Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery. N Engl J Med. 2010;363:1597–1607. - PubMed
-
- Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–2198. - PubMed
-
- U.S. Food and Drug Administration. [Accessed November 3, 2015];FDA approves SAPIEN 3 THV artificial heart valve. 2015 http://wwwfdagov/NewsEvents/Newsroom/PressAnnouncements/ucm451678htm.
-
- Popma JJ, Adams DH, Reardon MJ, et al. Transcatheter aortic valve replacement using a self-expanding bioprosthesis in patients with severe aortic stenosis at extreme risk for surgery. J Am Coll Cardiol. 2014;63:1972–81. - PubMed
-
- Mack MJ, Brennan J, Brindis R, et al. Outcomes following transcatheter aortic valve replacement in the United States. JAMA. 2013;310:2069–2077. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources